Cryptococcosis Market Size, Share, Growth, Trends, Consumption, Revenue, Company Analysis and Forecast 2022-2030

According to Vision Research Reports, the global cryptococcosis market size surpassed at US$ 5.29 Bn in 2021 and to reach US$ 7.79 billion by 2030 with a CAGR of 4.4% from 2022 to 2030.

Rise in reported cases of cryptococcosis, increase in research & developmental activities, surge in awareness, and rise in co-morbidities & risk factors boost the growth of the global cryptococcosis market.

Immediate Delivery Available | Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/36224

Pharmacotherapies using Drugs to Account for Leading Share of Global Market

• In terms of treatment type, the drugs segment accounted for major share of the global cryptococcosis market in 2020. The segment is anticipated to witness strong growth from 2022 to 2030.
• The drugs segment has been further categorized into Amphotericin B, Flucytosine, Fluconazole, and other antifungals. Amphotericin B drugs are further classified into Amphocin, Fungizone and other products. While Flucytosine drugs are further segmented into Ancobon and other products. Fluconazole includes Diflucan and other products. Among drug types, Flucytosine was the largest segment of the global cryptococcosis market in terms of revenue in 2020, driven by its increasing adoption in U.S. market along with high price of drugs. Amphotericin B and Fluconazole are projected to be lucrative segments of cryptococcosis market, which is attributed to increasing cryptococcosis prevalence in African countries.

Scope of The Report

Patent expiry of key drugs and entry of generics to Hamper Global Cryptococcosis Market

• The Cryptococcosis market experienced a patent cliff during the last decade. Expiration of patents affects the revenue of pharmaceutical companies. Moreover, generic version of a drug hampers the revenue of branded drug products.
• This factor is expected to have a profound impact on the cryptococcosis drugs market, causing a decline in market revenue. Moreover, approved ANDAs for most of these molecules will lead to intense generic competition. Increasing number of generic drugs and patent expirations will negatively affect the market. Hence, patent expirations are likely to restrain the Cryptococcosis market.

Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/36224

Retail Pharmacies Segment to Account for Significant Market Share

• Based on distribution channel, the global cryptococcosis market is segmented as hospital pharmacies, retail pharmacies, drug store, and mail order pharmacies. Retail pharmacy was the largest segment of the global market in terms of revenue in 2020 and is expected to continue its dominance by 2027, which is attributed to the increasing contribution of long term medication required for cryptococcosis treatment.
• Patients discharged from hospitals or diagnostic clinics with fungal infection treatment plan to use medication on a regular basis, prefer retail pharmacy purchase. Retail pharmacies located nearby are the most preferred buying options for patients with long term drug dosage.  Retail pharmacies are followed by mail order pharmacies which accounted for second largest share of global market in 2020. Rising preference for online sales for healthcare products in most of the regions of the world is the key factor that boost the demand for online pharmacies. Also, the segment is expected to register rapid growth due to increasing popularity, especially among developed countries such as the U.S., Germany and the U.K. Hospital pharmacies are the third leading segment for global cryptococcosis market.

Prominent Regions

• North America held the largest share of the global cryptococcosis market in 2020. The market in the region is projected to grow at a rapid pace during the forecast period, driven by presence of key players, technological advancements, and highly structured health care industry.
• North America is projected to continue its dominance in the global cryptococcosis market, by 2027, which is attributed to rising HIV infected population, highly structured health care industry, and well-defined reimbursement policies from public and private health insurance firms. The cryptococcosis market in Middle East & Africa is projected to have a substantial growth with contribution of Sub-Sahara African countries where burden of HIV is very high. North America and Middle East & Africa are projected to be the most lucrative regions for cryptococcosis market, while Europe, Asia Pacific, and Latin America are relatively smaller markets.

Key Players

• Key players in the global cryptococcosis market focus on strengthening their positions in the global market
• Major players operating in the global cryptococcosis market include Bristol-Myers Squibb Company, Janssen Biotech, Inc. (Johnson & Johnson), Abbott Laboratories, Novartis AG, Pfizer, Inc., Valeant Pharmaceuticals, Inc., Glenmark Pharmaceuticals and Sigmapharm Laboratories LLC.

Related Reports

• Artificial Intelligence As A Service Market Report 2022-2030 - https://www.visionresearchreports.com/artificial-intelligence-as-a-service-market/39918
• Intravascular Ultrasound Market Report 2022-2030 - https://www.visionresearchreports.com/intravascular-ultrasound-market/39917
• Biometrics As A Service In Healthcare Market Report 2022-2030 - https://www.visionresearchreports.com/biometrics-as-a-service-in-healthcare-market/39916

Market Segmentation

By Treatment

• • Amphotericin B
  • Amphocin
  • Fungizone
  • Other
  • Flucytosine
  • Ancobon
  • Other
  • Fluconazole
  • Diflucan
  • Other
  • Others (Voriconazole, Surgery Treatment, etc.)

BY Distribution Channel

• • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Store
  • Mail Order Pharmacies
  • Others

By Region

• • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/36224

You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333

Blog: https://www.novaoneadvisor.com/

Blog: https://qyresearchmedical.com/